This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ea Pharma Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Mizuki Kawahira: Innovator in Alpha-4 Beta-7 Integrin Inhibition
Introduction
Mizuki Kawahira is a notable inventor based in Chuo-ku, Japan. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit alpha-4 beta-7 integrin activity. Her work is crucial in advancing therapeutic options for various medical conditions.
Latest Patents
Kawahira holds a patent for "Substituted benzenesulfonamides as inhibitors of alpha-4 beta-7 integrin activity." This patent describes a compound that exhibits alpha-4 integrin inhibitory action. The compound is a sulfonamide derivative represented by a specific formula, which includes various substituents as detailed in the patent specification.
Career Highlights
Mizuki Kawahira is currently employed at Ea Pharma Co., Ltd., where she continues her research and development efforts. Her work at the company focuses on innovative solutions in the pharmaceutical industry, contributing to the advancement of medical treatments.
Collaborations
Kawahira collaborates with esteemed colleagues, including Munetaka Tokumasu and Masatsugu Noguchi. These partnerships enhance her research capabilities and foster a collaborative environment for innovation.
Conclusion
Mizuki Kawahira is a pioneering inventor whose work in integrin inhibition has the potential to impact therapeutic strategies significantly. Her contributions to the field exemplify the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile